Actively Recruiting
Comprehensive Connected Cancer Care (C4) Intervention Evaluation to Improve Patient-Centered Cancer Care
Led by Timothy Mullett · Updated on 2025-04-06
300
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
Sponsors
T
Timothy Mullett
Lead Sponsor
M
Merck Sharp & Dohme LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating the Comprehensive Connected Cancer Care (C4) program, which is designed to improve care coordination, patient communication, and supportive services for people with cancer. This program focuses on helping patients, healthcare teams, and healthcare systems work better together by using patient navigation, digital tools, and culturally appropriate educational resources. The study aims to see how these efforts affect patient-centered care and health outcomes for cancer patients. The study includes two phases: an 18-month Baseline Phase where patients receive usual care and data is collected, followed by an Implementation Phase where the C4 program is introduced. During the Implementation Phase, newly diagnosed cancer patients (not from the Baseline Phase) will be enrolled and the same data will be collected for comparison. The program offers patient navigation, digital needs assessments, referral systems, and healthcare team training to enhance communication and engagement. Participants will be asked to complete surveys and their electronic health records will be reviewed to assess outcomes such as health-related quality of life over four months and overall survival at 12 months. The study collects data on patient experiences, healthcare use, and supportive services to evaluate the program's effect. The total participation involves multiple months of follow-up and data collection to monitor these outcomes and support patient-centered care improvements.
CONDITIONS
Brief Title
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with newly diagnosed or recurrent cancer who have not started any treatment
- Patients with at least one social determinant of health need or at high risk based on race, ethnicity, or insurance status
- Willingness to provide informed consent to participate
You will not qualify if you...
- Unable to understand or communicate in English
- Unable or unwilling to access the internet using a phone, tablet, or computer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 18 months
Participants are observed during a period of usual care before the intervention is introduced. Data are collected via patient surveys and electronic health record abstraction.
Data collection over 4 months for most outcomes and 12 months for overall survival
Duration - Duration concurrent with observation period after baseline phase
Participants receive the C4 Program intervention which includes patient navigation, communication skills training for healthcare teams, and access to supportive services. Data collection continues as in the baseline phase.
Data collection at baseline and 4 months, with overall survival assessed at 12 months
Trial Site Locations
Total: 1 location
1
University of Kentucky
Lexington, Kentucky, United States, 40506
Actively Recruiting
Research Team
Y
Yvonne Taul, RN
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here